Secondary Prevention of Acute Coronary Events. Reduction of Cholesterol to Key European Targets [SPACE-ROCKET] - An open-label comparative investigation of efficacy, tolerance and health in 2,072 patients randomised to rosuvastatin or

Trial Profile

Secondary Prevention of Acute Coronary Events. Reduction of Cholesterol to Key European Targets [SPACE-ROCKET] - An open-label comparative investigation of efficacy, tolerance and health in 2,072 patients randomised to rosuvastatin or

Completed
Phase of Trial: Phase III

Latest Information Update: 11 Mar 2010

At a glance

  • Drugs Rosuvastatin; Simvastatin
  • Indications Acute coronary syndromes; Dyslipidaemias; Hypercholesterolaemia; Myocardial infarction; Myocardial ischaemia
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms SPACE-ROCKET
  • Most Recent Events

    • 11 Mar 2010 Actual end date (30 Apr 2006) added as reported by ClinicalTrials.gov.
    • 10 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ISRCTN: Current Controlled Trials record.
    • 11 Nov 2008 Results of a SPACE-ROCKET pharmacogenomics substudy presented at AHA 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top